Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: A population-based study

International Journal of Gynecological Cancer

Volumn 17, Issue 2, 2007, Pages 433-440

  Kwon, J S ^a   Carey, M S ^a   Cook, E F ^b   Qiu, F ^c   Paszat, L ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

Adjuvant pelvic radiotherapy; Endometrial cancer; Overall survival; Population based study; Surgical staging

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; COMORBIDITY; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MYOMETRIUM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL TIME;

AGED; CARCINOMA, ENDOMETRIOID; DIAGNOSTIC TECHNIQUES, SURGICAL; ENDOMETRIAL NEOPLASMS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33947269850     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00812.x     Document Type: Article

References (35)

1. Canadian Cancer Society, National Cancer Institute of Canada, Statistics Canada, Provincial/Territorial Cancer Registries, and Health Canada. Canadian cancer statistics 2005. Toronto, Canada: National Cancer Institute of Canada, 2005.
2. Kilgore LC, Partridge EE, Alvarez RD et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33.
3. Mohan DS, Samuels MA, Selim MA et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998;70:165-71.
4. Ng TY, Perrin LC, Nicklin JL, Cheuk R, Crandon AJ. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 2000;79:490-4.
5. Orr JW Jr, Holimon JL, Orr PF. Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 1997;176:777-88.
6. Straughn JM Jr, Huh WK, Kelly FJ et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 2002;84:194-200.
7. Fanning J Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 2001;82:371-4.
8. COSA-NZ-UK Endometrial Cancer Study Groups. Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer 1996;6:102-7.
9. Kitchener HK. 14th International Meeting of the European Society of Gynaecological Oncology (ESGO) Istanbul, Turkey, September 25-29 2005. Int J Gynecol Cancer 2005;15:51-184.
10. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419-27.
11. Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-11.
12. Keys HM, Roberts JA, Brunetto VL et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-51.
13. Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 2006;295:389-97.
14. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
15. PORTEC-2: Postoperative Radiation Therapy for Endometrial Carcinoma: a multicenter randomized phase III trial comparing external beam radiation and vaginal brachytherapy. Nederlands Trial Register. http://www.trialregister.nl/ trialreg/admin/retview.asp?TC=332 Accessed September 9, 2005.
16. Carey MS, O'Connell GJ, Johanson CR et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 1995;57:138-44.
17. Partridge EE, Shingleton HM, Menck HR. The National Cancer Data Base report on endometrial cancer. J Surg Oncol 1996;61:111-23.
18. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gadducci A. An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 1998;68:274-9.
19. Kennedy AW, Austin JM Jr, Look KY, Munger CB. The Society of Gynecologic Oncologists Outcomes Task Force. Study of endometrical cancer: initial experiences. Gynecol Oncol 2000;79:379-98.
20. Population and Dwelling Counts, for Canada, Provinces and Territories, 2001 and 1996 Censuses-100% Data. http://www12.statcan.ca/english/census01/ products/standard/popdwell/Table-PR.cfm. Statistics Canada, 2001.
21. Rush S, Gal D, Potters L, Bosworth J, Lovecchio J. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys 1995;33:851-4.
22. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol 1990;38:99-104.
23. Small W Jr, Erickson B, Kwakwa F. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int J Radiat Oncol Biol Phys 2005;63:1502-7.
24. Sykes P, Nam S, Wynne C et al. The pre-operative identification of low-risk endometrial cancer: an audit of women treated in the South Island of New Zealand 1998-2000. Aust N Z J Obstet Gynaecol 2002;42:387-90.
25. Frumovitz M, Singh DK, Meyer L et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 2004;95:463-8.
26. Eltabbakh G, Shamonki J, Mount S. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors. Gynecol Oncol 2005;99:109-12.
27. Kwon JS, Carey MS, Cook EF, Qiu F, Paszat L. Do prolonged wait times have an impact on survival in endometrial cancer? [abstract]. J Obstet Gynaecol Can 2006; 28(5 Suppl).
28. Briet JM, Hollema H, Reesink N et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 2005;96:799-804.
29. Cohn DE, Horowitz NS, Mutch DG, Kim SM, Manolitsas T, Fowler JM. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 2002;87:243-6.
30. Ambros RA, Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992;69:1424-31.
31. Tsuruchi N, Kaku T, Kamura T et al. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. Gynecol Oncol 1995;57:307-12.
32. Sivridis E, Buckley CH, Fox H. The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. Br J Obstet Gynaecol 1987;94:991-4.
33. Tu JV, Pinfold SP, McColgan P, Laupacis A. Access to Health Services in Ontario: ICES Atlas. April 2005. http://www.ices.on.ca/file/ Access_atlas_Chp7_v5.pdf#search=%22ICES%20Atlas%20and%20LHIN%
34. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health 2004;94:2104-11.
35. Simunovic M, Theriault ME, Paszat L et al. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can J Surg 2005;48:137-42.